MERCK KGaA MOBILE LAB DETECTS COUNTERFEIT MEDICINES WORLDWIDE
Merck funds the non-profit Global Pharma Health Fund (GPHF), which combats the spread of counterfeit medicines using trademark GPHF-Minilab™ technology. The mobile minilaboratory delivers rapid drug-quality verification and counterfeit medicines detection, providing low- and middle-income countries with a simple, low-cost screening method. Provided as a self-contained kit, the Minilab can verify 23 antimicrobials. Through 2018, GPHF supplied more than 800 sets to 97 countries.